Lataa...
Novel glucosylceramide synthase inhibitor based prodrug copolymer micelles for delivery of anticancer agents
In order to improve the efficacy of chemotherapy for cancers, we have developed a novel prodrug micellar formulation to co-deliver ceramide-generating anticancer agents and ceramide degradation inhibitor (PPMP). The prodrug nanocarrier is based on a well-defined POEG-b-PPPMP diblock copolymer. The h...
Tallennettuna:
| Julkaisussa: | J Control Release |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6177216/ https://ncbi.nlm.nih.gov/pubmed/30223045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2018.09.011 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|